PathoQuest Announces Appointment of Laurent Lafferrere as Chief Operating Officer
PARIS, FRANCE, April 27, 2020 – PathoQuest,a leading genomic expert in clinical diagnostics and biologics testing applications with innovative next-generation sequencing (NGS) approach, today announced the appointment of Dr....
Transgene chooses PathoQuest innovative NGS-based safety release test for TG4050 phase I clinical trial targeting patients with head-neck and ovarian cancers and for Invir.IO™ platform for recombinant viral vector manufacturing.
Transgene is a French biotechnology company focused on designing and developing next generation immunotherapeutics. In these phase 1 trials with 85 patients, Transgene has chosen PathoQuest next generation sequencing (NGS) solutions for its fast and cost-effective...
PathoQuest CEO Jean-François Brepson discusses “NGS and New Frontiers in Infectious Disease” during new Illumina Genomics podcast
In a new Illumina Genomics Podcast (Episode 53), Jean-François Brepson discusses the company’s vision of the impact of NGS on the diagnosis of infectious disease with the development of iDTECT™ blood, the company's CE-IVD NGS-based test that supports a more...
PathoQuest named 32nd most inventive start-up in France
100brevets.tech - Inventors of the French Tech Awards - has ranked PathoQuest as the 32nd most inventive start-up based in France and the 7th ranked MedTech company. See the list in as reported by Forbes at http://bit.ly/pathoquest-no32. . ...
PathoQuest Announces Appointment of Patrick Court as Chief Financial Officer
PARIS, FRANCE, July 22, 2019 – PathoQuest, a genomic expert dedicated to the microbiology testing market, leader in clinical diagnostics and biologics testing applications, today announced the appointment of Patrick Court as the Company's CFO. Mr. Court joins the...
Read our Latest Newsletter – Learn What’s New with PathoQuest’s Biologics Genomic Service
Click here or on the image to view our latest newsletter to learn about recent news from PathoQuest, new service offerings from PathoQuest’s Biologics Genomics Service and upcoming events and meetings we will be exhibiting at.
Join us at Charles River’s 4th Annual Viral Safety and Viral Clearance Summit: October 8-9, 2019 in San Francisco
PathoQuest's strategic partner, Charles River Labs, will be sponsoring their 4th Annual Viral Safety and Viral Clearance Summit on October 8-9, 2019 in San Francisco. This two-day event unites leading experts on viral safety and viral clearance with...
PathoQuest announces publication in Biologicals reporting on a new RNA-based NGS approach for adventitious viruses detection
PathoQuest continues to demonstrate its leadership and expertise associated with the detection of adventitious viruses with the recent publication of a new RNA-based NGS method for this use. The paper, entitled "Use of a new RNA next generation sequencing approach for...
PathoQuest joins MabDesign
PathoQuest is now a member of MabDesign, a membership organization dedicated to the creation of a unique environment that allows the economic development and growth of the French industrial sector in the field of therapeutic antibody and immunotherapy.
PathoQuest achieves Illumina Propel Certification
PathoQuest is pleased to announce that it has received Propel Certification from Illumina after successfully completing the requirements for achieving this recognition. This included demonstrating the ability to produce high-quality data on the NexSeq System following...